MétaCan
Menu
Back to cohort
Record W4389617190 · doi:10.1038/s41467-023-44071-8

Author Correction: Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial

2023· erratum· en· W4389617190 on OpenAlexaff
Laurence Buisseret, Delphine Loirat, Philippe Aftimos, Christian Maurer, Kevin Punie, Véronique Debien, Paulus Kristanto, Daniel Eiger, Anthony Gonçalvès, François Ghiringhelli, Donatienne Taylor, Florent Clatot, Tom Van den Mooter, Jean-­Marc Ferrero, Hervé Bonnefoi, Jean-Luc Canon, François P. Duhoux, Laura Mansi, Renaud Poncin, Philippe Barthélémy, Nicolás Isambert, Zoë Denis, Xavier Catteau, Roberto Salgado, Elisa Agostinetto, Evandro de Azambuja, Françoise Rothé, Ligia Craciun, David Venet, Emanuela Romano, John Stagg, Marianne Paesmans, Denis Larsimont, Christos Sotiriou, Michail Ignatiadis, Martine Piccart

Bibliographic record

VenueNature Communications · 2023
Typeerratum
Languageen
FieldMedicine
TopicAdvanced Breast Cancer Therapies
Canadian institutionsCentre Hospitalier de l’Université de Montréal
Fundersnot available
KeywordsTriple-negative breast cancerCarboplatinPaclitaxelDurvalumabMedicineMetastatic breast cancerOncologyBreast cancerTriple negativeRandomized controlled trialInternal medicineCancerChemotherapyCisplatinNivolumabImmunotherapy

Abstract

fetched live from OpenAlex

In the “Discussion” section of the original manuscript, the authors reported information and data related to an unpublished work ( Metoikidou C. and colleagues) . Considering the confidential nature of these data, it has been decided to remove the related paragraph from the “Discussion” section. The original text has been replaced with the following statement:

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Science and technology studies, Research integrity
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Other · Consensus signal: none
Teacher disagreement score0.660
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0030.000
Bibliometrics0.0000.002
Science and technology studies0.0010.002
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0010.004
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.027
GPT teacher head0.362
Teacher spread0.335 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designRandomized trial
Domainnot available
GenreOther

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueNature CommunicationsSame topicAdvanced Breast Cancer TherapiesFrench-language works237,207